| Customization: | Available |
|---|---|
| Powder: | Yes |
| Customized: | Customized |
Suppliers with verified business licenses
Audited Supplier Audited by an independent third-party inspection agency
| Name | Enrofloxacin hydrochloride | CAS No. | 112732-17-9 |
| Molecule Formula | C10H10O4 |
MOQ is 0.1kg |
10g free sample |
| Molecular Weight | 395.86 | ||
| Specification | 99% | ||
| Test Method | HPLC | ||
| Appearance | Light yellow or wjite crystalline powder | Extraction Type | Solvent extraction |
| Grade | Phamaceutical and food | Brand | Biocar |
Enrofloxacin hydrochloride, light yellow crystalline powder, slightly bitter taste.This product is slightly dissolved in water or ethanol.It is a wide range of antimicrobial drugs, to all kinds of gram positive bacteria, negative bacteria.Including stubborn mycoplasma disease, chronic respiratory diseases and so on.
Enrofloxacin HCL is a broad spectrum bactericidal drugs,have special effects on mycoplasma.White on escherichia coli, klebsiella bacillus coli,pseudomonas aeruginosa,salmonella,deformation,haemophilus, kill,pasteurella,streptococcus hemolytic pap coli,s.aureus bacteria, such as have antiseptic effect
Enrofloxacin hydrochloride is a broad spectrum bactericidal drugs, have special effects on mycoplasma. White on escherichia coli, klebsiella bacillus coli, pseudomonas aeruginosa, salmonella, deformation, haemophilus, kill, pasteurella, streptococcus hemolytic pap coli, s. aureus bacteria, such as have antiseptic effect.
1.Dogs and Cats
The product is indicated in the treatment of bacterial infections of the alimentary, respiratory and urogenital tracts, skin, secondary wound infections and otitis externa where clinical experience, supported where possible by sensitivity testing of the causal organism, indicates enrofloxacin as the drug of choice.
2.Cattle
Diseases of the respiratory and alimentary tract of bacterial or mycoplasmal origin (e.g. pasteurellosis, mycoplasmosis, coli-bacillosis, coli-septicaemia and salmonellosis) and secondary bacterial infections subsequent to viral conditions (e.g. viral pneumonia) where clinical experience, supported where possible by sensitivity testing of the causal organism, indicates enrofloxacin as the drug of choice.
3.Pigs
Diseases of the respiratory and alimentary tract of bacterial or mycoplasmal origin (e.g. pasteurellosis, actinobacillosis, mycoplasmosis, coli-bacillosis, coli-septicaemia and salmonellosis) and mulifactorial diseases such as atrophic rhinitis and enzootic pneumonia, where clinical experience, supported where possible by sensitivity testing of the causal organism, indicates enrofloxacin as the drug of choice.
){kind=link}